Top Markets
Coin of the day
Achilles Therapeutics plc Achilles Therapeutics plc

Achilles Therapeutics plc

ACHL
Rankning i aktier #24579
Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused... Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused on immuno-oncology. The firm specializes in creating innovative precision T-cell therapies designed to combat a range of solid tumors. Its primary therapeutic candidates, both currently undergoing Phase I/IIa clinical trials, are CHIRON, aimed at advanced non-small cell lung cancer, and THETIS, targeting metastatic or recurrent melanoma. Beyond these, Achilles is also advancing its pipeline with treatments for head and neck squamous cell carcinoma, renal cell carcinoma, triple-negative breast cancer, and bladder cancer. Initially incorporated as Achilles TX Limited, the company officially adopted the name Achilles Therapeutics Plc in February 2021. Established in 2016, its corporate headquarters are situated in London, United Kingdom.
Aktiekurs
$1.48
Senast synkroniserad: 2025-03-24
Marknadsvärde
$59.05M
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
GB
Handel Achilles Therapeutics plc (ACHL)

Kategori

Aktiekurshistorik för Achilles Therapeutics plc (ACHL)
Högsta slutkurs: $1.42 den 2025-03-01

Lägsta slutkurs: $16.55 den 2021-03-01
Aktiekurshistorik för Achilles Therapeutics plc från 2021 till 2026
Årlig aktiekursutveckling
År Prestanda
2025 35.96%
2024 21.05%
2023 -23.13%
2022 -77.06%
2021 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$547.38 37.72%
US
$1.05K 58.85%
NL
$118.70 -18.24%
AU
$140.47 435.74%
US
$770.19 9.84%
CH